News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
227,339 Results
Type
Article (14294)
Company Profile (84)
Press Release (212961)
Multimedia
Podcasts (14)
Webinars (2)
Section
Business (63018)
Career Advice (392)
Deals (11728)
Drug Delivery (29)
Drug Development (44091)
Employer Resources (21)
FDA (4866)
Job Trends (4807)
News (119574)
Policy (8655)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (2)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
Academia (897)
Accelerated approval (3)
Adcomms (11)
Allergies (33)
Alliances (18667)
ALS (53)
Alzheimer's disease (953)
Antibody-drug conjugate (ADC) (120)
Approvals (4872)
Artificial intelligence (131)
Autoimmune disease (20)
Automation (2)
Bankruptcy (73)
Best Places to Work (4432)
BIOSECURE Act (8)
Biosimilars (34)
Biotechnology (77)
Bladder cancer (28)
Brain cancer (22)
Breast cancer (189)
Cancer (1548)
Cardiovascular disease (99)
Career advice (309)
Career pathing (6)
CAR-T (113)
Cell therapy (280)
Cervical cancer (12)
Clinical research (35631)
Collaboration (514)
Compensation (205)
Complete response letters (11)
COVID-19 (966)
CRISPR (30)
C-suite (111)
Cystic fibrosis (64)
Data (1432)
Decentralized trials (1)
Depression (20)
Diabetes (122)
Diagnostics (2109)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (84)
Drug pricing (31)
Drug shortages (3)
Duchenne muscular dystrophy (53)
Earnings (26807)
Editorial (13)
Employer branding (2)
Employer resources (19)
Events (37031)
Executive appointments (307)
FDA (5487)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (399)
Gene editing (83)
Generative AI (14)
Gene therapy (167)
GLP-1 (347)
Government (1142)
Grass and pollen (2)
Guidances (26)
Healthcare (6179)
Huntington's disease (17)
IgA nephropathy (23)
Immunology and inflammation (95)
Indications (15)
Infectious disease (1043)
Inflammatory bowel disease (105)
Inflation Reduction Act (5)
Influenza (22)
Intellectual property (62)
Interviews (53)
IPO (6513)
IRA (14)
Job creations (651)
Job search strategy (246)
Kidney cancer (6)
Labor market (1)
Layoffs (141)
Leadership (5)
Legal (1001)
Liver cancer (43)
Lung cancer (241)
Lymphoma (98)
Machine learning (3)
Management (8)
Manufacturing (103)
MASH (42)
Medical device (2515)
Medtech (2517)
Mergers & acquisitions (5545)
Metabolic disorders (346)
Multiple sclerosis (54)
NASH (14)
Neurodegenerative disease (51)
Neuropsychiatric disorders (11)
Neuroscience (1267)
NextGen: Class of 2025 (1682)
Non-profit (879)
Northern California (1521)
Now hiring (2)
Obesity (179)
Opinion (90)
Ovarian cancer (61)
Pain (59)
Pancreatic cancer (53)
Parkinson's disease (94)
Partnered (8)
Patents (131)
Patient recruitment (68)
Peanut (15)
People (15925)
Pharmaceutical (16)
Pharmacy benefit managers (6)
Phase I (13277)
Phase II (16264)
Phase III (10283)
Pipeline (831)
Policy (39)
Postmarket research (656)
Preclinical (5468)
Press Release (18)
Prostate cancer (73)
Psychedelics (14)
Radiopharmaceuticals (204)
Rare diseases (237)
Real estate (967)
Recruiting (9)
Regulatory (7462)
Reports (18)
Research institute (962)
Resumes & cover letters (117)
Rett syndrome (4)
RNA editing (4)
RSV (23)
Schizophrenia (41)
Series A (87)
Series B (44)
Sickle cell disease (32)
Southern California (1307)
Special edition (5)
Spinal muscular atrophy (97)
Sponsored (14)
Startups (1457)
State (1)
Stomach cancer (10)
Supply chain (17)
Tariffs (7)
The Weekly (13)
United States (11330)
Vaccines (295)
Venture capitalists (18)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Today (5)
Last 7 days (225)
Last 30 days (1268)
Last 365 days (17831)
2025 (5020)
2024 (18778)
2023 (20428)
2022 (24745)
2021 (24183)
2020 (20420)
2019 (14512)
2018 (10666)
2017 (11690)
2016 (9938)
2015 (11922)
2014 (7881)
2013 (5999)
2012 (6115)
2011 (6287)
2010 (5499)
Location
Africa (166)
Alabama (12)
Alaska (2)
Arizona (35)
Arkansas (5)
Asia (15139)
Australia (2901)
California (3346)
Canada (912)
China (328)
Colorado (133)
Connecticut (170)
Delaware (76)
Europe (35042)
Florida (421)
Georgia (84)
Idaho (9)
Illinois (180)
India (10)
Indiana (129)
Iowa (2)
Japan (104)
Kansas (21)
Kentucky (7)
Louisiana (1)
Maine (42)
Maryland (375)
Massachusetts (2579)
Michigan (53)
Minnesota (125)
Mississippi (1)
Missouri (27)
Montana (1)
Nebraska (2)
Nevada (15)
New Hampshire (6)
New Jersey (826)
New Mexico (12)
New York (896)
North Carolina (359)
North Dakota (3)
Northern California (1521)
Ohio (66)
Oklahoma (1)
Oregon (16)
Pennsylvania (644)
Puerto Rico (7)
Rhode Island (11)
South America (221)
South Carolina (3)
Southern California (1307)
Tennessee (16)
Texas (471)
Utah (68)
Virginia (82)
Washington D.C. (11)
Washington State (324)
Wisconsin (19)
227,339 Results for "target pharmasolutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mikart and Nano PharmaSolutions complete key milestones
Mikart, LLC, a leading contract development and manufacturing organization, is thrilled to announce a significant milestone in its collaboration with Nano PharmaSolutions, Inc..
May 7, 2024
·
2 min read
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Immunology and Inflammation
I&I Investment Ramps Up With Novel Targets and Boundless Opportunity
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and more.
February 17, 2025
·
5 min read
·
Kate Goodwin
Neuroscience
Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Kura Oncology to Participate in Stifel Targeted Oncology Forum
April 1, 2025
·
2 min read
Neuroscience
Annexon Touts ‘Rapid’ and ‘Durable’ Improvements for Targeted Guillain-Barré Therapy
Jefferies analysts predict Annexon’s tanruprubart could be approved by mid-2026.
April 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum
April 1, 2025
·
1 min read
Press Releases
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
April 7, 2025
·
2 min read
Press Releases
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
April 3, 2025
·
1 min read
Press Releases
Trispecific Antibodies Unlocking New Promises In Targeted Therapies
March 18, 2025
·
3 min read
1 of 22,734
Next
